About
Small Molecule for Bone Disease
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
86
By Phase
PHASE1/PHASE2: 1PHASE2: 2
By Status
RECRUITING: 2UNKNOWN: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06011109Lead Sponsor
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PHASE1/PHASE2Recruiting
30 participants
Started: Dec 13, 2023 · Completed: Jan 31, 2026
NCT05865028Collaborator
A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia
PHASE2Recruiting
32 participants
Started: May 24, 2023 · Completed: May 24, 2028
NCT05312710Lead Sponsor
Safety and Efficacy of APG-157 in Head and Neck Cancer
PHASE2Unknown
24 participants
Started: Apr 22, 2022 · Completed: Dec 31, 2024
NCT05551013Lead Sponsor
Treatment of Recurrent GBM With APG-157 Via Expanded Access
N/ANO_LONGER_AVAILABLE
Locations (1)
Headquarters
Bedford, MA, United States
Map
Loading map...